Home

Tiago Girao

CIK 1618670 · Chief Financial Officer · last filed 2026-07-24

Tiago Girao is a Chief Financial Officer who has filed 23 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider sold $263.0K of IMVT on Jul 24, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.61M

Companies

3

Total Filings

23

Lifetime Open-Market Net

-$1.38M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IMVT Chief Financial Officer 240,798 $39.90 $9.61M -$1.41M 5 2026-07-24
Landos Biopharma, Inc. (LABP) Delisted Director — $22.93 — $0 5 2024-05-23
PLUS THERAPEUTICS, INC. (CYTX) Delisted VP & Chief Financial Officer 14,084 — — $33.1K 11 2017-11-29

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-24 IMVT Sell (S) −6,798 -$263.0K EDGAR
2026-06-26 IMVT Notice (144) −10,000 -$384.6K EDGAR
2026-06-26 IMVT Mixed — -$225.6K EDGAR
2026-04-24 IMVT Sell (S) −25,760 -$763.0K EDGAR
2026-04-09 IMVT Grant (A) +64,968 $0 EDGAR
2025-05-05 IMVT Grant (A) +208,388 $0 EDGAR
2024-05-23 Landos Biopharma, Inc. (LABP) Delisted Disp (D) — $0 EDGAR
2023-05-24 Landos Biopharma, Inc. (LABP) Delisted Grant (A) — $0 EDGAR
2022-06-09 Landos Biopharma, Inc. (LABP) Delisted Grant (A) — $0 EDGAR
2022-05-18 Landos Biopharma, Inc. (LABP) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.